April 24, 2013

Sanofi Pasteur to Provide 1.7 Billion Doses of Oral Polio Vaccine from 2013 to 2017 for Polio Eradication

Company also expands injectable polio vaccine production capacity to respond to the World Health Organization’s endgame strategy

 

Sanofi Pasteur to Provide 1.7 Billion Doses of Oral Polio Vaccine from 2013 to 2017 for Polio Eradication
Company also expands injectable polio vaccine production capacity to respond to the World Health Organization’s endgame strategy

Lyon, France – April 24, 2013 – Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), announced today its commitment to provide 1.7 billion doses of oral polio vaccine (OPV) to support the Global Polio eradication Initiative’s (GPEI) strategy to eradicate polio this decade. The doses of OPV will be delivered through 2017 for GPEI polio vaccination program.